Leveraging Nanotechnology in Generic Drug Development: Enhancing Efficacy and Safety

Nanotechnology has greatly advanced the pharmaceutical industry, particularly in developing generic drugs. By using nanoparticles, drug developers can improve bioavailability, enable targeted delivery, enhance stability, and reduce toxicity. Challenges include regulatory frameworks, cost-effectiveness, and the need for personalized therapies. Despite these hurdles, nanotechnology has the potential to revolutionize generic drug production and improve patient outcomes.